Logo image of IVVD

INVIVYD INC (IVVD) Stock Fundamental Analysis

NASDAQ:IVVD - Nasdaq - US00534A1025 - Common Stock - Currency: USD

0.792  -0.06 (-6.82%)

After market: 0.798 +0.01 (+0.76%)

Fundamental Rating

3

IVVD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 559 industry peers in the Biotechnology industry. The financial health of IVVD is average, but there are quite some concerns on its profitability. IVVD has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year IVVD has reported negative net income.
In the past year IVVD has reported a negative cash flow from operations.
In the past 5 years IVVD always reported negative net income.
In the past 5 years IVVD always reported negative operating cash flow.
IVVD Yearly Net Income VS EBIT VS OCF VS FCFIVVD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

IVVD's Return On Assets of -137.57% is on the low side compared to the rest of the industry. IVVD is outperformed by 84.08% of its industry peers.
IVVD has a Return On Equity of -263.57%. This is in the lower half of the industry: IVVD underperforms 71.02% of its industry peers.
Industry RankSector Rank
ROA -137.57%
ROE -263.57%
ROIC N/A
ROA(3y)-93.62%
ROA(5y)-74.61%
ROE(3y)-143.77%
ROE(5y)-106.92%
ROIC(3y)N/A
ROIC(5y)N/A
IVVD Yearly ROA, ROE, ROICIVVD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

IVVD's Gross Margin of 93.32% is amongst the best of the industry. IVVD outperforms 94.45% of its industry peers.
IVVD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 93.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IVVD Yearly Profit, Operating, Gross MarginsIVVD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

5

2. Health

2.1 Basic Checks

IVVD does not have a ROIC to compare to the WACC, probably because it is not profitable.
IVVD has more shares outstanding than it did 1 year ago.
IVVD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IVVD Yearly Shares OutstandingIVVD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
IVVD Yearly Total Debt VS Total AssetsIVVD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -15.20, we must say that IVVD is in the distress zone and has some risk of bankruptcy.
IVVD has a Altman-Z score of -15.20. This is amonst the worse of the industry: IVVD underperforms 80.68% of its industry peers.
There is no outstanding debt for IVVD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -15.2
ROIC/WACCN/A
WACC16.01%
IVVD Yearly LT Debt VS Equity VS FCFIVVD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 1.53 indicates that IVVD should not have too much problems paying its short term obligations.
IVVD's Current ratio of 1.53 is on the low side compared to the rest of the industry. IVVD is outperformed by 81.40% of its industry peers.
A Quick Ratio of 1.53 indicates that IVVD should not have too much problems paying its short term obligations.
IVVD has a Quick ratio of 1.53. This is amonst the worse of the industry: IVVD underperforms 80.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.53
IVVD Yearly Current Assets VS Current LiabilitesIVVD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

IVVD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.16%, which is quite impressive.
EPS 1Y (TTM)33.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.16%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 34.21% on average over the next years. This is a very strong growth
Based on estimates for the next years, IVVD will show a very strong growth in Revenue. The Revenue will grow by 90.29% on average per year.
EPS Next Y107.76%
EPS Next 2Y60.97%
EPS Next 3Y44.44%
EPS Next 5Y34.21%
Revenue Next Year440.77%
Revenue Next 2Y239.09%
Revenue Next 3Y170.21%
Revenue Next 5Y90.29%

3.3 Evolution

IVVD Yearly Revenue VS EstimatesIVVD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
IVVD Yearly EPS VS EstimatesIVVD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IVVD. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 0.90, the valuation of IVVD can be described as very cheap.
Based on the Price/Forward Earnings ratio, IVVD is valued cheaply inside the industry as 99.28% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of IVVD to the average of the S&P500 Index (22.13), we can say IVVD is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.9
IVVD Price Earnings VS Forward Price EarningsIVVD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVVD Per share dataIVVD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IVVD's earnings are expected to grow with 44.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.97%
EPS Next 3Y44.44%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IVVD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INVIVYD INC

NASDAQ:IVVD (6/13/2025, 8:12:01 PM)

After market: 0.798 +0.01 (+0.76%)

0.792

-0.06 (-6.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)08-06 2025-08-06/amc
Inst Owners64.67%
Inst Owner ChangeN/A
Ins Owners13.76%
Ins Owner Change0%
Market Cap95.01M
Analysts80
Price Target5.03 (535.1%)
Short Float %11.36%
Short Ratio3.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-177.78%
Min EPS beat(2)-357.52%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-102.19%
Min EPS beat(4)-357.52%
Max EPS beat(4)1.96%
EPS beat(8)3
Avg EPS beat(8)-55.71%
EPS beat(12)6
Avg EPS beat(12)-31.38%
EPS beat(16)8
Avg EPS beat(16)-19.6%
Revenue beat(2)0
Avg Revenue beat(2)-33.98%
Min Revenue beat(2)-67.83%
Max Revenue beat(2)-0.13%
Revenue beat(4)0
Avg Revenue beat(4)-47.55%
Min Revenue beat(4)-67.83%
Max Revenue beat(4)-0.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-25.25%
PT rev (3m)-26%
EPS NQ rev (1m)-474.81%
EPS NQ rev (3m)-225%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-28.28%
Revenue NQ rev (3m)-32.51%
Revenue NY rev (1m)-22.65%
Revenue NY rev (3m)-22.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.9
P/S 2.59
P/FCF N/A
P/OCF N/A
P/B 1.75
P/tB 1.75
EV/EBITDA N/A
EPS(TTM)-1.25
EYN/A
EPS(NY)0.88
Fwd EY111.19%
FCF(TTM)-1.18
FCFYN/A
OCF(TTM)-1.18
OCFYN/A
SpS0.31
BVpS0.45
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -137.57%
ROE -263.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 93.32%
FCFM N/A
ROA(3y)-93.62%
ROA(5y)-74.61%
ROE(3y)-143.77%
ROE(5y)-106.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.33%
Cap/Sales 0.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 1.53
Altman-Z -15.2
F-Score4
WACC16.01%
ROIC/WACCN/A
Cap/Depr(3y)1436.61%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.16%
EPS Next Y107.76%
EPS Next 2Y60.97%
EPS Next 3Y44.44%
EPS Next 5Y34.21%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year440.77%
Revenue Next 2Y239.09%
Revenue Next 3Y170.21%
Revenue Next 5Y90.29%
EBIT growth 1Y32.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year111.09%
EBIT Next 3Y26.91%
EBIT Next 5Y18.42%
FCF growth 1Y30.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.04%
OCF growth 3YN/A
OCF growth 5YN/A